XBIO Xenetic Biosciences Inc

P/E --
Forward P/E --
Price/Sales 2.075
Beta 2.2
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ Xenetic Biosciences is trading 5.6% down today; immediate reason remains unclear

Xenetic Biosciences is trading 5.6% down at $3.12, with no clear company-specific catalyst identified for August 13, 2026. - The latest reported event was its...

πŸ”΄ Xenetic Biosciences is trading 5.6% down in pre-market with no clear catalyst

Xenetic Biosciences is trading 5.58% down at $3.12 in pre-market, with no company-specific announcement identified for August 13, 2026. - The latest...

πŸ”΄ Xenetic Biosciences is trading 5.12% down in after-hours trading with no company-specific announcement identified

Xenetic Biosciences is trading 5.12% down at $3.13 after no new company-specific announcement was identified for August 12, 2026. - The latest release, dated...

🟒 Xenetic Biosciences is trading 6.47% up today after Q2 results and formal strategic review

Xenetic Biosciences is trading 6.47% up now at $3.29 as investors continue reacting to its August 7, 2026, second-quarter results and formal strategic...

πŸ”΄ Xenetic Biosciences is trading 6.3% down today in pre-market after wider second-quarter loss

Xenetic Biosciences is trading 6.3% down at $2.97 in pre-market after August 7 second-quarter report highlighted a wider $0.9 million net loss. - Royalty...

Xenetic Biosciences Inc Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026

Analysts have provided limited formal coverage for Xenetic Biosciences heading into its Q2 2026 report, with no official consensus revenue or EPS estimates...

🟒 Xenetic Biosciences is trading 6.3% up today after reporting a $930,000 quarterly loss

Xenetic Biosciences is trading 6.3% up now at $3.02 after reporting a $930,000 quarterly loss. - Second-quarter 2026 results, released August 7, 2026,...

🟒 Xenetic Biosciences is trading 5% up today, extending a multi-day rebound amid sector strength

Xenetic Biosciences is trading 5% up today at $2.95, extending a multi-day rebound in its share price. β€’ The move appears driven by broader risk-on sentiment...

🟒 Xenetic Biosciences is trading 12% up today amid a broader risk-on rally and rotation into high-beta biotech stocks

Xenetic Biosciences is trading 12% up at $2.98 amid a broader risk-on rally in U.S. equities and strength in the biotech sector. β€’ Market commentators...

🟒 Xenetic Biosciences is trading 9.2% up today as traders rotate into high-beta biotech names

Xenetic Biosciences is trading 9.2% up today at $2.89 amid speculative momentum and a broader risk-on tone in U.S. equities. β€’ The move appears driven by...

🟒 Xenetic Biosciences is trading 9.4% up today amid speculative momentum and broader risk-on sentiment

Xenetic Biosciences is trading at $2.75 (+9.40%) in pre-market sessions on speculative momentum and broader risk-on sentiment. - The stock closed at $2.66 on...

🟒 Xenetic Biosciences is trading 10.4% up today on speculative momentum despite no fresh news

Xenetic Biosciences is trading 10.4% up at $2.94 on speculative momentum despite a lack of company-specific news. β€’ The stock's after-hours jump follows a...

🟒 Xenetic Biosciences is trading 6.38% up today, extending gains with no clear catalyst

Xenetic Biosciences is trading at $2.67 (+6.38%) today, extending gains from the previous session despite a lack of fresh company filings, press releases, or...

🟒 Xenetic Biosciences is trading 5.6% up today, extending gains without a clear catalyst

Xenetic Biosciences is trading 5.6% up at $2.62, extending yesterday’s gains despite a weak backdrop for the broader biotechnology sector. β€’ There are no...

🟒 Xenetic Biosciences is trading 5.8% up today with no clear company-specific catalyst

Xenetic Biosciences is trading at $2.55 (+5.81%) with no direct catalyst found to explain the move. β€’ The gain likely reflects normal small-cap volatility or...

🟒 Xenetic Biosciences is trading 5.6% up today, rebounding from a previous drop amid high volatility

Xenetic Biosciences is trading at $2.64 (5.6% up) in pre-market as the stock rebounds from a 5.3% drop at the July 27 close. β€’ Recent price action appears to...

🟒 Xenetic Biosciences is trading 7.2% up today with no clear catalyst identified

Xenetic Biosciences is trading at $2.68 (7.2% up) following a volatile week that saw the stock close at $2.50 on July 27. - There are no fresh...

πŸ”΄ Xenetic Biosciences is trading 7% down today on no apparent news

Xenetic Biosciences is trading approximately 7% down today at $2.50 with no fresh, stock-specific news or filings explaining the move. β€’ The decline appears...

πŸ”΄ Xenetic Biosciences is trading 5.6% down today, underperforming the broader biotech sector

Xenetic Biosciences is trading 5.6% down today at $2.70, underperforming a broadly positive biotech sector and stronger overall U.S. equity markets. β€’ The...

πŸ”΄ Xenetic Biosciences is trading 5.6% down today amid a broader pullback in high-risk growth sectors

Xenetic Biosciences is trading 5.6% down today at $2.74 amid a broader pullback in higher-risk growth sectors. β€’ The decline follows a general risk-off...